Clinical trial
Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT06291116 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease
- Lead sponsor
- University Hospital, Rouen
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 12, 2026
- Completion date
- July 1, 2030
- Enrollment
- 120 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.